Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of New Biologics (Vedolizumab and Ustekinumab) and Small Molecules (Tofacitinib) During Pregnancy: A Review
Authors
Keywords
-
Journal
DRUGS
Volume 80, Issue 11, Pages 1085-1100
Publisher
Springer Science and Business Media LLC
Online
2020-06-19
DOI
10.1007/s40265-020-01346-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JAK inhibitors safety in ulcerative colitis: practical implications
- (2020) Manasi Agrawal et al. Journal of Crohns & Colitis
- Inflammatory Bowel Disease (IBD) in Pregnancy Clinical Care Pathway – A Report from the American Gastroenterological Association IBD Parenthood Project Working Group
- (2019) Uma Mahadevan et al. GASTROENTEROLOGY
- Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate
- (2019) Ariella Bar-Gil Shitrit et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group
- (2019) Uma Mahadevan et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Eficacia de tofacitinib en el tratamiento de la colitis ulcerosa
- (2019) Julián Panés et al. Gastroenterologia y Hepatologia
- Biologics exposure during pregnancy and breastfeeding in a psoriasis patient
- (2019) Cristina Mugheddu et al. Dermatologic Therapy
- A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy
- (2019) Sherman Picardo et al. DRUGS
- Evaluation of the Developmental Toxicity of Vedolizumab, an α4β7 Receptor Antagonist, in Rabbit and Nonhuman Primate
- (2019) David Crawford et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
- (2019) Annick Moens et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice
- (2019) Javier P Gisbert et al. Journal of Crohns & Colitis
- Editorial: effects of vedolizumab during pregnancy in the CONCEIVE study
- (2019) Rachel W. Winter ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease
- (2018) M. Julsgaard et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study
- (2018) M Chaparro et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines
- (2018) Dawn B. Beaulieu et al. Clinical Gastroenterology and Hepatology
- Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development
- (2018) Rebecca Matro et al. GASTROENTEROLOGY
- Vedolizumab Concentrations in the Breast Milk of Nursing Mothers With Inflammatory Bowel Disease
- (2018) Mette Julsgaard et al. GASTROENTEROLOGY
- Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
- (2018) Uma Mahadevan et al. INFLAMMATORY BOWEL DISEASES
- Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab
- (2018) Marco Galluzzo et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system
- (2018) Jantien W. Wieringa et al. Expert Review of Gastroenterology & Hepatology
- Ustekinumab Exposure during Conception and Pregnancy in Patients with Chronic Plaque Psoriasis - a case series of 10 pregnancies
- (2018) N. Watson et al. BRITISH JOURNAL OF DERMATOLOGY
- Letter to the editor submitted in response to “psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab”
- (2018) Matteo Megna et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- The use of biologics and small molecules in pregnant patients with rheumatic diseases
- (2018) Maria Gerosa et al. Expert Review of Clinical Pharmacology
- Letter: vedolizumab drug concentrations in neonates following intrauterine exposure
- (2018) Emma Flanagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
- (2018) Annick Moens et al. Journal of Crohns & Colitis
- Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn’s Disease
- (2018) Entcho Klenske et al. Journal of Crohns & Colitis
- Ustekinumab en el tratamiento de la enfermedad de Crohn
- (2017) Javier P. Gisbert et al. Gastroenterologia y Hepatologia
- Placental MadCAM1 Expression and Potential Consequences for the Treatment with Vedolizumab during Pregnancy
- (2017) Zuzana Zelinkova et al. GASTROENTEROLOGY
- Vedolizumab safety in pregnancy and newborn outcomes
- (2017) Mette Julsgaard et al. GUT
- Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease
- (2017) Adi Lahat et al. Journal of Crohns & Colitis
- Ustekinumab Drug Levels in Maternal and Cord Blood in a Woman With Crohn’s Disease Treated Until 33 Weeks of Gestation
- (2017) Catherine R Rowan et al. Journal of Crohns & Colitis
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin 23 regulates the functions of human decidual immune cells during early pregnancy
- (2016) Jun-Ying Cai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
- (2016) Megan E. B. Clowse et al. DRUG SAFETY
- 437 Do Infant Serum Levels of Biologic Agents at Birth Correlate With Risk of Adverse Outcomes? Results From the PIANO Registry
- (2016) Uma Mahadevan et al. GASTROENTEROLOGY
- Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
- (2016) Mette Julsgaard et al. GASTROENTEROLOGY
- “Just in Time”: When Is It Safe to Administer Live Vaccines to Infants Exposed to Anti-Tumor Necrosis Factor Agents In Utero?
- (2016) Cynthia H. Seow et al. GASTROENTEROLOGY
- The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
- (2016) Geoffrey C. Nguyen et al. GASTROENTEROLOGY
- Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature
- (2016) X. Cortes et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differences in Cytokine Expression and STAT3 Activation between Healthy Controls and Patients of Unexplained Recurrent Spontaneous Abortion (URSA) during Early Pregnancy
- (2016) JunYing Cai et al. PLoS One
- Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
- (2015) M. Rosario et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pregnancy during Ustekinumab Treatment for Severe Psoriasis
- (2015) Katiucia Rocha et al. DERMATOLOGY
- Vedolizumab en el tratamiento de la enfermedad de Crohn
- (2015) Javier P. Gisbert et al. Gastroenterologia y Hepatologia
- Introducing Vedolizumab to Clinical Practice: Who, When, and How?
- (2015) RV Bryant et al. Journal of Crohns & Colitis
- Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis
- (2015) E. Galli-Novak et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester
- (2014) Claire Sheeran et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?
- (2014) María Chaparro et al. Expert Opinion On Drug Safety
- Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results
- (2014) Tim Wyant et al. GUT
- Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis
- (2014) A. Alsenaid et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease
- (2013) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease
- (2013) M J Casanova et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
- (2012) Maria Chaparro et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Intrauterine Growth Restriction: Cytokine Profiles of Trophoblast Antigen-Stimulated Maternal Lymphocytes
- (2011) Raj Raghupathy et al. Clinical & Developmental Immunology
- Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease
- (2011) Shomron Ben-Horin et al. Journal of Crohns & Colitis
- Fatal case of disseminated BCG infection after vaccination of an infant with in utero exposure to infliximab
- (2011) Misha M. Heller et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Umbilical Cord Serum Cytokine Levels and Risks of Small-for-Gestational-Age and Preterm Birth
- (2010) G. I. Neta et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
- (2010) Uma Mahadevan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation
- (2010) Pauline L. Martin et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding
- (2009) Javier P. Gisbert INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started